GGrantIndex
← Leaderboards

Loren C Denlinger

University Of Wisconsin-Madison

$6,188,666
Attributed
$23,618,790
Total exposure
5
Grants
4
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $4.3M · FY200823
$5M$3.8M$2.5M$1.3M$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23

Funding mix

By agency

NIH$23,618,790 · 5

By mechanism

U01$17,276,351 · 1
R01$2,376,836 · 1
UG1$2,224,084 · 1
P01$1,313,839 · 1
K23$427,680 · 1

Top collaborators

Most similar at University Of Wisconsin-Madison

Same institution · by research overlap

Others in their field

Top investigators on “Asthma

Research focus

AsthmaPhenotypeProgramsBaseSeveritiesRespiratorySputumSamplingMorbidity - Disease RateFutureAirway InflammationReceptorResponseResolutionTherapeutic DevelopmentDisease ProgressionDesignMolecularMonitorAsthmatic PatientProtocols DocumentationTargeted TreatmentInvestigationCharacteristics

Grant awards (26)

Immunometabolic phenotypes in adult severe asthma and disease progression$3,233,979
U01 · FY2023 · HL
Immunometabolic phenotypes in adult severe asthma and disease progression$216,239
U01 · FY2023 · HL
Immunometabolic phenotypes in adult severe asthma and disease progression$3,322,614
U01 · FY2022 · HL
Rapid saliva antigen test for SARS-CoV-2 detection$434,002
U01 · FY2022 · HL
The Great Lakes PrecISE Partnership$345,292
UG1 · FY2022 · HL · contact PI
Immunometabolic phenotypes in adult severe asthma and disease progression$235,989
U01 · FY2022 · HL
Immunometabolic phenotypes in adult severe asthma and disease progression$3,058,207
U01 · FY2021 · HL
The Great Lakes PrecISE Partnership$384,084
UG1 · FY2021 · HL · contact PI
Immunometabolic phenotypes in adult severe asthma and disease progression$3,355,708
U01 · FY2020 · HL
The Great Lakes PrecISE Partnership$384,084
UG1 · FY2020 · HL · contact PI
Immunometabolic phenotypes in adult severe asthma and disease progression$3,419,613
U01 · FY2019 · HL
The Great Lakes PrecISE Partnership$395,614
UG1 · FY2019 · HL · contact PI
The Great Lakes PrecISE Partnership$382,671
UG1 · FY2018 · HL · contact PI
Nucleotide receptor modulation of airway eicosanoids during asthma exacerbations$468,878
R01 · FY2017 · HL · contact PI
The Great Lakes PrecISE Partnership$332,339
UG1 · FY2017 · HL · contact PI
Nucleotide receptor modulation of airway eicosanoids during asthma exacerbations$468,878
R01 · FY2016 · HL · contact PI
Nucleotide receptor modulation of airway eicosanoids during asthma exacerbations$482,615
R01 · FY2015 · HL · contact PI
Nucleotide receptor modulation of airway eicosanoids during asthma exacerbations$480,164
R01 · FY2014 · HL · contact PI
Nucleotide receptor modulation of airway eicosanoids during asthma exacerbations$476,301
R01 · FY2013 · HL · contact PI
Investigative Bronchoscopy and Analysis$326,452
P01 · FY2011 · HL · contact PI
Investigative Bronchoscopy and Analysis$326,452
P01 · FY2010 · HL · contact PI
Variant Nucleotide Receptor Function in Airway Disorders$142,560
K23 · FY2010 · HL · contact PI
Investigative Bronchoscopy and Analysis$326,452
P01 · FY2009 · HL · contact PI
Variant Nucleotide Receptor Function in Airway Disorders$142,560
K23 · FY2009 · HL · contact PI
Investigative Bronchoscopy and Analysis$334,483
P01 · FY2008 · HL · contact PI
Variant Nucleotide Receptor Function in Airway Disorders$142,560
K23 · FY2008 · HL · contact PI